Lexicon Pharmaceuticals, Inc. (LXRX)

1.62 -0.04 (-2.41%) USD  |  NASDAQ  |  Apr 29, 09:59
More

Lexicon Pharmaceuticals Research and Development Expense (TTM) : 60.50M for Dec. 31, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for LXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Viemed Healthcare, Inc. 3.017M
ANI Pharmaceuticals, Inc. 51.66M
Novavax, Inc. 338.72M
Kura Oncology, Inc. 251.07M
Liquidia Corp. 38.35M